We are pleased to share the new look Bunzl plc website, where you can discover…
23rd June 2021
The Insides™ System, a novel chyme reinfusion medical device for intestinal failure, has won the James & Wells Medical Technology Association of New Zealand (MTANZ) Innovation Award for 2021, presented at the Health Tech Week Gala Dinner in Auckland.
The Insides System is developed by The Insides Company and exclusively distributed in New Zealand by Obex Medical, who presented the technology to the judging panel at the Gala Dinner.
The MTANZ Innovation award is a prestigious award that recognises innovation from both locally New Zealand-developed and imported medical technologies that significantly contribute to improving patient outcomes and quality of life. Each year, the winner of the MTANZ Innovation Award is judged by a panel of distinguished industry stakeholders and health professionals.
MTANZ is the only industry body representing medical technology manufacturers, importers, exporters, and distributors of medical devices in New Zealand. The key focus of MTANZ is to engage with policymakers, regulators, and healthcare professionals to ensure optimum patient access to medical technology.
Obex is an industry leader in advancing clinical education and has a high level of clinical and technical expertise with a strong focus on meeting the changing needs of healthcare in Australasia. Obex’s purpose is to meet the needs of healthcare professionals with the supply of minimally invasive consumable and implantable devices which will enable the delivery of the best diagnosis and therapy to ensure the best outcomes for patients.
“We are thrilled to have The Insides System announced as the winner of the 2021 MTANZ Innovation. We thank the judging panel for their recognition of The Insides System as a medical technology of innovation excellence that significantly contributes to improving patient outcomes, following severe colorectal diseases. We would also like to thank our New Zealand distributor Obex Medical Limited for their support and partnership”, said Garth Sutherland, CEO of The Insides Company.
Pictured Left: Professor Greg O’Grady, Co-founder and Chief Scientific Officer at The Insides Company
Pictured Right: Phil Scott, Business Unit Manager at Obex Medical Limited
The Insides™ Company Limited is a leading provider of therapeutic chyme reinfusion solutions for intestinal failure resulting from high-output enteroatmospheric fistulas and high-output ileostomies.